Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Benjamin Scirica"'
Autor:
Leon M. Ptaszek, Christopher W. Baugh, Steven A. Lubitz, Jeremy N. Ruskin, Grace Ha, Margaux Forsch, Samer A. DeOliveira, Samia Baig, E. Kevin Heist, Jason H. Wasfy, David F. Brown, Paul D. Biddinger, Ali S. Raja, Benjamin Scirica, Benjamin A. White, Moussa Mansour
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 18 (2019)
Background Variability in the management of atrial fibrillation (AF) in the emergency department (ED) leads to avoidable hospital admissions and prolonged length of stay (LOS). In a retrospective single‐center study, a multidisciplinary AF treatmen
Externí odkaz:
https://doaj.org/article/14aef57d85434a8096ad1a3ed3618d6c
Autor:
Danielle J. Daly, Utibe R. Essien, Marcela G. del Carmen, Benjamin Scirica, Adam N. Berman, Jennifer Searl Como, Jason H. Wasfy
Publikováno v:
Journal of the National Medical Association.
Autor:
Bertram Pitt, Barry Reicher, Richard Gilbert, Benjamin Scirica, Karl Swedberg, Anna Langkilde, John Monyak, Natalia Zaozerska, Mikhail Kosiborod
Publikováno v:
Journal of Cardiac Failure. 28:S92-S93
Publikováno v:
The New England journal of medicine. 384(22)
Autor:
Anne Hellkamp, Laine Thomas, Luis Gruberg, James L. de Lemos, Tracy Wang, Amr Mohsen, Jonathan Enriquez, Benjamin Scirica, Anthony Hilliard
Publikováno v:
Journal of the American College of Cardiology. 65(10)
Autor:
Amarinder Bindra, Eric Bates, John Spertus, David Maron, Pamela M. Hartigan, Steven P. Sedlis, Benjamin Scirica, William E. Boden, William J. Kostuk, William S. Weintraub, Mandeep S. Sidhu, G.B. John Mancini, Bernard Chaitman, Koon K. Teo
Publikováno v:
Journal of the American College of Cardiology. 61(10)
Autor:
David A Morrow, Mark Alberts, Jay P Mohr, Sebastian Ameriso, Marc Bonaca, Shinya Goto, Graeme J Hankey, Sabina Murphy, Benjamin Scirica, Philip Teal, Eugene Braunwald
Publikováno v:
Stroke. 44
Vorapaxar is an antiplatelet agent that potently inhibits thrombin-mediated activation of the platelet protease-activated receptor (PAR)-1. Phase 2 trials of vorapaxar suggested efficacy with acceptable safety in patients with ischemic stroke. Method
Autor:
Nadia Sutton, James de Lemos, James C. Fang, Christopher Granger, Laine Thomas, Rashmee U. Shah, Tracy Y. Wang, Benjamin Scirica, Anita Chen, Timothy Henry
Publikováno v:
Journal of the American College of Cardiology. 65:A187
Publikováno v:
Cardiovascular Engineering: An International Journal; Mar2009, Vol. 9 Issue 1, p18-26, 9p
Autor:
Benjamin Scirica, Matthew T. Roe, Daniel Munoz, Matthew Dupree, James Jollis, Monique L. Anderson, Debra B. Diercks, Michael C. Kontos
Publikováno v:
Journal of the American College of Cardiology. (10):E16
The presence of cardiac arrest (CA) in patients (pts) with ST elevation MI (STEMI) is associated with worse outcomes, but the processes of care and outcomes for these pts have not been assessed in contemporary US practice. We evaluated STEMI pts enro